Credit Suisse Upgrades AstraZeneca (AZN) to Outperform
Tweet
Share
E-mail
Get Alerts AZN Hot Sheet
Price: $92.77 --0%
Rating Summary:
19 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 16
Rating Summary:
19 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 10 | New: 16
Join SI Premium – FREE
Credit Suisse upgraded AstraZeneca (NYSE: AZN) from Neutral to Outperform.
For an analyst ratings summary and ratings history on AstraZeneca click here. For more ratings news on AstraZeneca click here.
Shares of AstraZeneca closed at $34.61 Friday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades L'Oreal SA (OR:FP) (LRLCY) to Sell
- H.C. Wainwright Starts Seres Therapeutics (MCRB) at Buy
- Kepler Cheuvreux Upgrades Kone OYJ (KNEBV:FH) (KNYJY) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Hot Upgrades, UpgradesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
